Related references
Note: Only part of the references are listed.Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients
Luigi E. Adinolfi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments
Hidenori Toyoda et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Ming-Lung Yu et al.
CLINICAL CANCER RESEARCH (2017)
Global epidemiology and burden of HCV infection and HCV-related disease
Aaron P. Thrift et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Apolipoprotein(a) Inhibits Hepatitis C Virus Entry Through Interaction With Infectious Particles
Catarina Oliveira et al.
HEPATOLOGY (2017)
Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
Lauren A. Beste et al.
JOURNAL OF HEPATOLOGY (2017)
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents
Jee-Fu Huang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review
Giacomo Gastaldi et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis
Philip Vutien et al.
PLOS ONE (2017)
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Michelle C. M. Cheung et al.
JOURNAL OF HEPATOLOGY (2016)
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
JOURNAL OF HEPATOLOGY (2016)
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Michael P. Curry et al.
GASTROENTEROLOGY (2015)
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
Raymond T. Chung et al.
HEPATOLOGY (2015)
Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C A Nationwide Survey in Taiwan
Ming-Lung Yu et al.
MEDICINE (2015)
HCV Genotype 3 Is Associated With an Increased Risk of Cirrhosis and Hepatocellular Cancer in a National Sample of US Veterans With HCV
Fasiha Kanwal et al.
HEPATOLOGY (2014)
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
Ludovico Abenavoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Half a Diagnosis: Gap in Confirming Infection among Hepatitis C Antibody-positive Patients
Emily McGibbon et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
Alexander J. Thompson et al.
GUT (2012)
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
Maxine M. Denniston et al.
HEPATOLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial
Jee-Fu Huang et al.
JOURNAL OF HEPATOLOGY (2011)
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
G. Nkontchou et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis
A. Probst et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection
Brian J. McMahon et al.
GASTROENTEROLOGY (2010)
Abnormalities of lipid metabolism in hepatitis C virus infection
Francesco Negro
GUT (2010)
Public Health Impact of Antiviral Therapy for Hepatitis C in the United States
Michael L. Volk et al.
HEPATOLOGY (2009)
Treatment of chronic hepatitis C in Asia: When East meets West
Ming-Lung Yu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
HEPATITIS C VIRUS INFECTION AND METABOLIC SYNDROME-A COMMUNITY-BASED STUDY IN AN ENDEMIC AREA OF TAIWAN
Jee-Fu Huang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2009)
Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection
Jee-Fu Huang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: An epidemiological link with virological implication
Jee-Fu Huang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Glucose abnormalities in patients with hepatitis C virus infection -: Epidemiology and pathogenesis
A Lecube et al.
DIABETES CARE (2006)
Hepatitis C and steatosis: a reappraisal
A Lonardo et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
JM Petit et al.
JOURNAL OF HEPATOLOGY (2001)
Hepatitis C virus induced hypobetalipoproteinemia:: a possible mechanism for steatosis in chronic hepatitis C
L Serfaty et al.
JOURNAL OF HEPATOLOGY (2001)
Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection
H Knobler et al.
MAYO CLINIC PROCEEDINGS (2000)
Share Paper
